Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck total Company Sales — Worldwide ($M) ($M)
Form 8-K Table 3 / 3a / 3b & Form 10-Q / 10-K
Latest, Q2 2026
16,607
Period ended Jun 30, 2026
Change on a year earlier
+5.1%
15,806 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
10
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total company sales — worldwide ($m)
- Total Company Sales — United States ($M)9,367 · Q2 2026
- Total Company Sales — International ($M)7,240 · Q2 2026
- Other Revenues (alliance, royalty & third-party supply) — Worldwide ($M)72 · Q2 2026
- Total Company Sales — Worldwide reported growth YoY (%)5.0% · Q2 2026
- Total Company Sales — Worldwide constant-currency (ex-exchange) growth YoY (%)4.0% · Q2 2026
Cite this data
StockData. (2026). Merck Total Company Sales — Worldwide ($M) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev_company_total
See every metric in the Merck KPI table. Data updated Oct 26, 2026.